The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing ...

Researchers at Ruhr University Bochum, Germany, identified a receptor that plays a crucial role in stress-induced motor incoordination associated with ataxias. These hereditary motor disorders have ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing ...

A green light would have made Vyglxia the first and only FDA-approved treatment for spinocerebellar ataxia, a life-threatening neurodegenerative disease characterized by progressive loss of voluntary ...

Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia. ・The company is in the process ...

A FATHER of two young kids has been diagnosed with a disease so rare, treatment isn’t available from the NHS. Daniel Fraser, 36, from Gorebridge, suffers from Friedreich’s Ataxia, a progressive ...

Biohaven stock was down 40% in pre-market trading on Wednesday, following a 6.06% fall yesterday. The stock has also ...

“They were able to see during that time that Lottie had a flicker in her eyes,” Mrs Garrett said. It was then doctors ...

Not a day goes by when Harry Cross doesn't miss his wife. He misses how she gently used to tease him, how she organised his life with quiet efficiency, how she was never lost for the right words to co ...

When the Fillingame family started homesteading, they had no intention of creating a business – but that is what the ...

The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Biohaven regarding the New Drug Application (NDA) for troriluzole for the treatment of adults with spinocerebellar ...